MicroRNAs | Disease progression high → low | Clinical outcome | MiRNA property (Initial analysis) | MiRNA property (Meta-analysis) | Prognosis |
---|---|---|---|---|---|
High → low | |||||
miR-3681 | CR/R/C | A/D/C | Oncogene | Oncogene | Inferior |
miR-601 | CR/R/C | A/D/C | Oncogene | Tumor-suppressor gene | Favorable |
miR-320e | R/CR/C | D/A/C | Oncogene | Tumor-suppressor gene | Favorable |
miR-34a | R/CR/C | N/A | Oncogene | Oncogene | Inferior |
miR-642a | CR/R/C | A/D/C | Oncogene | Tumor-suppressor gene | Favorable |
miR-720 | C/CR/R | C/A/D | Tumor-suppressor gene | Tumor-suppressor gene | Favorable |
miR-891a | C/R/CR | C/D/A | Tumor-suppressor gene | Tumor-suppressor gene | Favorable |
miR-522 | C/R/CR | N/A | Tumor-suppressor gene | Oncogene | Inferior |
miR-518c | C/CR/R | N/A | Tumor-suppressor gene | Oncogene | Inferior |
miR-3665 | C/CR/R | N/A | Tumor-suppressor gene | Tumor-suppressor gene | Favorable |
miR-3620 | C/CR/R | N/A | Tumor-suppressor gene | Tumor-suppressor gene | Favorable |
miR-382 | C/CR/R | N/A | Tumor-suppressor gene | Tumor-suppressor gene | Favorable |
miR-452 | C/CR/R | N/A | Tumor-suppressor gene | Tumor-suppressor gene | Favorable |
miR-136 | R/CR/C | A/D/C | Oncogene | Oncogene | Inferior |
miR-26b | CR/R/C | A/D/C | Oncogene | Oncogene | Inferior |
miR-122 | C/CR/R | N/A | Tumor-suppressor gene | Tumor-suppressor gene | Favorable |
miR-147 | C/CR/R | N/A | Tumor-suppressor gene | Oncogene | Inferior |
miR-192 | R/CR/C | N/A | Oncogene | Oncogene | Inferior |